OLD Second National Bank of Aurora Boosts Stock Position in Zoetis Inc. $ZTS

OLD Second National Bank of Aurora lifted its stake in Zoetis Inc. (NYSE:ZTS) by 118.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 29,933 shares of the company’s stock after acquiring an additional 16,240 shares during the period. OLD Second National Bank of Aurora’s holdings in Zoetis were worth $4,380,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in ZTS. Nova Wealth Management Inc. bought a new position in Zoetis in the 1st quarter worth about $25,000. Halbert Hargrove Global Advisors LLC lifted its holdings in shares of Zoetis by 496.6% in the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after buying an additional 144 shares in the last quarter. REAP Financial Group LLC boosted its position in shares of Zoetis by 201.5% in the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock valued at $31,000 after acquiring an additional 131 shares during the period. NewSquare Capital LLC grew its stake in Zoetis by 69.1% during the second quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock valued at $32,000 after acquiring an additional 85 shares in the last quarter. Finally, 1248 Management LLC bought a new stake in Zoetis during the 1st quarter worth approximately $35,000. 92.80% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

ZTS has been the subject of several analyst reports. The Goldman Sachs Group raised shares of Zoetis to a “buy” rating in a report on Monday, December 15th. HSBC set a $140.00 target price on Zoetis in a research note on Wednesday, December 10th. UBS Group dropped their price target on Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. Barclays initiated coverage on Zoetis in a report on Monday, December 8th. They set an “equal weight” rating and a $136.00 price objective for the company. Finally, BTIG Research reaffirmed a “buy” rating and issued a $160.00 target price on shares of Zoetis in a research note on Wednesday, December 3rd. Six analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Zoetis has a consensus rating of “Hold” and a consensus price target of $160.18.

Zoetis Stock Performance

Shares of NYSE ZTS opened at $125.77 on Monday. The stock’s 50-day moving average is $125.02 and its 200 day moving average is $141.51. The stock has a market cap of $55.43 billion, a price-to-earnings ratio of 21.17, a P/E/G ratio of 2.57 and a beta of 0.97. Zoetis Inc. has a 1-year low of $115.25 and a 1-year high of $177.40. The company has a current ratio of 3.64, a quick ratio of 2.28 and a debt-to-equity ratio of 1.31.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The business had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.42 billion. During the same period last year, the business earned $1.58 earnings per share. The business’s quarterly revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 3rd. Shareholders of record on Tuesday, January 20th will be paid a $0.53 dividend. This is a boost from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, January 20th. Zoetis’s payout ratio is presently 33.67%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.